Inspect Point has partnered with Dyne Fire Protection Labs to connect sprinkler sampling and lab testing with inspection workflows.
Monday, Dyne Therapeutics Inc (NASDAQ:DYN) released clinical data from its ongoing Phase 1/2 ACHIEVE trial of DYNE-101 in patients with myotonic dystrophy type 1 (DM1) and its ongoing Phase 1/2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results